Biochemistry
-
A SARS‐CoV‐2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD‐Independent Mechanism**
This article has 7 authors:Reviewed by ScreenIT
-
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
This article has 10 authors:Reviewed by ScreenIT
-
A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2
This article has 7 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors
This article has 14 authors:Reviewed by ScreenIT
-
O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins
This article has 11 authors:Reviewed by ScreenIT
-
Biparatopic sybodies neutralize SARS‐CoV‐2 variants of concern and mitigate drug resistance
This article has 23 authors:Reviewed by ScreenIT
-
A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors
This article has 10 authors:Reviewed by ScreenIT
-
UVA radiation could be a significant contributor to sunlight inactivation of SARS-CoV-2
This article has 6 authors:Reviewed by ScreenIT
-
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process
This article has 15 authors:Reviewed by ScreenIT
-
Design, Expression, Purification, and Characterization of a YFP-Tagged 2019-nCoV Spike Receptor-Binding Domain Construct
This article has 5 authors:Reviewed by ScreenIT